Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining.

Dager, William E

Dager, William E.

Affiliation

Dager WE; University of California-Davis Medical Center, Sacramento, CA, USA. william.dager@ucdmc.ucdavis.edu

Ann Pharmacother ; 46(1): 79-88, 2012 Jan.

Article in En | MEDLINE | ID: mdl-22202495

Subject(s)

Anticoagulants/therapeutic use; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Postoperative Complications/prevention & control; Practice Guidelines as Topic; Venous Thromboembolism/prevention & control; Warfarin/therapeutic use; Anticoagulants/administration & dosage; Anticoagulants/adverse effects; Clinical Trials as Topic; Humans; Postoperative Complications/blood; Postoperative Complications/etiology; Venous Thromboembolism/blood; Venous Thromboembolism/etiology; Warfarin/administration & dosage; Warfarin/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Postoperative Complications / Warfarin / Practice Guidelines as Topic / Arthroplasty, Replacement, Hip / Arthroplasty, Replacement, Knee / Venous Thromboembolism / Anticoagulants Type of study: Etiology_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2012 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google